Biodegradable double-j stent and method of manufacturing the same
US-2024299197-A1 · Sep 12, 2024 · US
US10543299B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10543299-B2 |
| Application number | US-201715724135-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 3, 2017 |
| Priority date | Oct 3, 2016 |
| Publication date | Jan 28, 2020 |
| Grant date | Jan 28, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein are substrate coatings.
Opening claim text (preview).
We claim: 1. A method of functionalizing a surface of an implantable medical device, the method including: depositing a dopamine or dopamine-like compound on the surface to form a functionalized surface; and depositing phosphorylethanolamine on the functionalized surface. 2. The method of claim 1 , further comprising depositing a diamine, multifunctional amine, or multifunctional amine polymer on the functionalized surface. 3. The method of claim 1 , further comprising conjugating a phosphate containing compound onto the functionalized surface. 4. The method of claim 3 , wherein the phosphate containing compound is phosphorylcholine. 5. The method of claim 1 , wherein the dopamine or dopamine-like compound is 6. A method of functionalizing a surface of an implantable medical device, the method including: depositing a dopamine or dopamine-like compound on the surface to form a functionalized surface; and depositing taurine on the functionalized surface. 7. The method of claim 6 , further comprising depositing a diamine, multifunctional amine, or multifunctional amine polymer on the functionalized surface. 8. The method of claim 6 , further comprising conjugating a phosphate containing compound onto the functionalized surface. 9. The method of claim 8 , wherein the phosphate containing compound is phosphorylcholine. 10. The method of claim 6 , wherein the dopamine or dopamine-like compound is 11. A method of functionalizing a surface of an implantable medical device, the method including: depositing a dopamine or dopamine-like compound on the surface to form a functionalized surface; and depositing a primary amine zwitterion on the functionalized surface. 12. The method of claim 11 , further comprising depositing a diamine, multifunctional amine, or multifunctional amine polymer on the functionalized surface. 13. The method of claim 11 , further comprising conjugating a phosphate containing compound onto the functionalized surface. 14. The method of claim 13 , wherein the phosphate containing compound is phosphorylcholine. 15. The method of claim 11 , wherein the dopamine or dopamine-like compound is
Means for introducing or releasing pharmaceutical products into the body · CPC title
rectangular · CPC title
Modification of implant surfaces in order to improve biocompatibility, cell growth, fixation of biomolecules, e.g. plasma treatment · CPC title
Designing or manufacturing processes · CPC title
made from perforated sheets or tubes, e.g. perforated by laser cuts or etched holes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.